STAT(@statnews):Tomorrow at 1 p.m. ET: Biosimilars: Have We Reached an Inflection Point? STAT’s Ed Silverman will moderate a virtual conversation with experts about the next wave of biosimilars, shifting FDA policies and what’s next for the market. Join us online.

STAT

@statnews

Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here:

Joined July 2015

4.7K Following 165.1K Followers

STAT@statnews

2026.09.23 21:00

Tomorrow at 1 p.m. ET: Biosimilars: Have We Reached an Inflection Point? STAT’s Ed Silverman will moderate a virtual conversation with experts about the next wave of biosimilars, shifting FDA policies and what’s next for the market. Join us online.